This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

In reality, the only people who clearly need a multivitamin are those with “a problem absorbing food or on an extremely ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

Leann Poston, a physician and medical-content expert for Invigor Medical, suggests checking products for the seal from the United States Pharmacopeia (USP). Another thing to check for is the ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

The Biologics Price Competition and Innovation Act (BPCIA) of 2010 initially posed significant barriers to biosimilar ...

CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The global industrial alcohol market is expected to witness growth at a CAGR of 7.6% in the forecast period (2022-2032) and ...